Literature DB >> 21451438

Transient heat hyperalgesia during resolution of ropivacaine sciatic nerve block in the rat.

Lavinia M Kolarczyk1, Brian A Williams.   

Abstract

BACKGROUND: Preliminary studies using perineural sciatic ropivacaine in rat demonstrated unexpected heat hyperalgesia after block resolution. To better characterize the time course relative to mechanical anesthesia-analgesia, we tested the hypothesis that ropivacaine 0.5% leads to transient heat hyperalgesia in rats independent of mechanical nociception. We also evaluated functional toxicity (eg, long-term hyperalgesia and/or tactile allodynia 2 weeks after injection).
METHODS: Under surgical exposure, left sciatic nerve block was performed in 2 groups of adult male rats-ropivacaine (200 μL, 5 mg/mL; n = 14) versus vehicle (n = 11). The efficacy and duration of block were assessed with serial heat, mechanical (Randall-Selitto testing), and tactile (von Frey-like monofilaments) tests; motor-proprioceptive (rotating rod) and sedation tests were used at 1 and 7 hrs after injection. The presence of nerve injury was assessed by repeating the heat, tactile, and motor tests 12 to 14 days after injection.
RESULTS: Ropivacaine-induced anesthesia was fully manifest at 1 hr after injection. At 3 hrs after injection, heat hypersensitivity was present in the setting of resolved mechanical analgesia. All behavioral measures returned to baseline by 2 weeks after injection. There was no evidence of (i) behavioral sedation, (ii) persistent changes in heat or mechanical sensitivity, or (iii) persistent changes in proprioceptive-motor function at 12 to 14 days after injection.
CONCLUSIONS: Ropivacaine 0.5% induces transient heat hyperalgesia in the setting of resolved mechanical analgesia, further suggestive of modality and/or nociceptive fiber specificity. Whether this finding partially translates to "rebound pain" after patients' nerve blocks wear off requires further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451438      PMCID: PMC3085276          DOI: 10.1097/AAP.0b013e3182176f5a

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  18 in total

1.  Effects of levobupivacaine and ropivacaine on rat sciatic nerve blood flow.

Authors:  H Bouaziz; G Iohom; J-P Estèbe; W M Campana; R R Myers
Journal:  Br J Anaesth       Date:  2005-09-23       Impact factor: 9.166

2.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

3.  Femoral-sciatic nerve blocks for complex outpatient knee surgery are associated with less postoperative pain before same-day discharge: a review of 1,200 consecutive cases from the period 1996-1999.

Authors:  Brian A Williams; Michael L Kentor; Molly T Vogt; John P Williams; Jacques E Chelly; Stacey Valalik; Christopher D Harner; Freddie H Fu
Journal:  Anesthesiology       Date:  2003-05       Impact factor: 7.892

4.  The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat.

Authors:  H Dyhre; M Lång; R Wallin; H Renck
Journal:  Acta Anaesthesiol Scand       Date:  1997-11       Impact factor: 2.105

5.  Long-term evaluation of motor function following intraneural injection of ropivacaine using walking track analysis in rats.

Authors:  G Iohom; G B Lan; D P Diarra; Y Grignon; B P Kinirons; F Girard; M Merle; G Granier; V Cahn; H Bouaziz
Journal:  Br J Anaesth       Date:  2005-02-04       Impact factor: 9.166

6.  Sciatic nerve blockade in infant, adolescent, and adult rats: a comparison of ropivacaine with bupivacaine.

Authors:  D S Kohane; W N Sankar; M Shubina; D Hu; N Rifai; C B Berde
Journal:  Anesthesiology       Date:  1998-11       Impact factor: 7.892

7.  Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay.

Authors:  Vanessa C Z Anseloni; Matthew Ennis; Michael S Lidow
Journal:  J Neurosci Methods       Date:  2003-12-30       Impact factor: 2.390

8.  Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog.

Authors:  H S Feldman; B G Covino
Journal:  Anesth Analg       Date:  1988-11       Impact factor: 5.108

9.  Neurologic evaluation of the rat during sciatic nerve block with lidocaine.

Authors:  J G Thalhammer; M Vladimirova; B Bershadsky; G R Strichartz
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

10.  Rebound pain scores as a function of femoral nerve block duration after anterior cruciate ligament reconstruction: retrospective analysis of a prospective, randomized clinical trial.

Authors:  Brian A Williams; Matthew T Bottegal; Michael L Kentor; James J Irrgang; John P Williams
Journal:  Reg Anesth Pain Med       Date:  2007 May-Jun       Impact factor: 6.288

View more
  11 in total

1.  Forecast for perineural analgesia procedures for ambulatory surgery of the knee, foot, and ankle: applying patient-centered paradigm shifts.

Authors:  Brian A Williams
Journal:  Int Anesthesiol Clin       Date:  2012

2.  Regional anesthesia does not decrease opioid demand in pelvis and acetabulum fracture surgery.

Authors:  Daniel J Cunningham; J Patton Robinette; Ariana R Paniagua; Micaela A LaRose; Michael Blatter; Mark J Gage
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-09-14

3.  Effect of Transauricular Vagus Nerve Stimulation on Rebound Pain After Ropivacaine Single Injection Femoral Nerve Block for Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial.

Authors:  Qi Zhou; Lili Yu; Chunping Yin; Qi Zhang; Yanlei Tai; Lian Zhu; Jiangtao Dong; Qiujun Wang
Journal:  J Pain Res       Date:  2022-07-14       Impact factor: 2.832

4.  Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study.

Authors:  Jacques T YaDeau; Michael A Gordon; Enrique A Goytizolo; Yi Lin; Kara G Fields; Amanda K Goon; Guilherme Holck; Timothy W Miu; Lawrence V Gulotta; David M Dines; Edward V Craig
Journal:  Pain Med       Date:  2015-12-14       Impact factor: 3.750

5.  Dexamethasone as adjuvant to bupivacaine prolongs the duration of thermal antinociception and prevents bupivacaine-induced rebound hyperalgesia via regional mechanism in a mouse sciatic nerve block model.

Authors:  Ke An; Nabil M Elkassabany; Jiabin Liu
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

6.  Ultrasound-Guided Transversus Abdominis Plane Block for Cesarean Delivery: Injection Site Pain as a New Complication and Dexamethasone Reduced Incidence.

Authors:  Hai-Lin Liu; Rui-Hao Zhou; He-Guo Luo; Li-Li Luo; Xue Yuan; Ling Ye
Journal:  J Pain Res       Date:  2020-03-19       Impact factor: 3.133

7.  The effect of perineural dexamethasone on rebound pain after ropivacaine single-injection nerve block: a randomized controlled trial.

Authors:  Jie Fang; Yuncen Shi; Fang Du; Zhanggang Xue; Jing Cang; Changhong Miao; Xiaoguang Zhang
Journal:  BMC Anesthesiol       Date:  2021-02-12       Impact factor: 2.217

8.  Regional anesthesia does not decrease inpatient or outpatient opioid demand in distal femur fracture surgery.

Authors:  Daniel J Cunningham; Ariana R Paniaugua; Micaela A LaRose; Isabel F DeLaura; Michael K Blatter; Mark J Gage
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-03       Impact factor: 2.928

Review 9.  Does Rebound Pain after Peripheral Nerve Block for Orthopedic Surgery Impact Postoperative Analgesia and Opioid Consumption? A Narrative Review.

Authors:  Olufunke Dada; Alicia Gonzalez Zacarias; Corinna Ongaigui; Marco Echeverria-Villalobos; Michael Kushelev; Sergio D Bergese; Kenneth Moran
Journal:  Int J Environ Res Public Health       Date:  2019-09-05       Impact factor: 3.390

Review 10.  [Peripheral nerve block and rebound pain: literature review].

Authors:  Layana Vieira Nobre; Graziella Prianti Cunha; Paulo César Castello Branco de Sousa; Alexandre Takeda; Leonardo Henrique Cunha Ferraro
Journal:  Braz J Anesthesiol       Date:  2019-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.